Research

Research

81600 bookmarks
Newest
Clinical Features and Mortality of Nosocomial Candidemia in Very Old Patients: A Multicentre Italian Study | Gerontology | Karger Publishers
Clinical Features and Mortality of Nosocomial Candidemia in Very Old Patients: A Multicentre Italian Study | Gerontology | Karger Publishers
Abstract. Introduction: Being elderly is a well-known risk factor for candidemia, but few data are available on the prognostic impact of candidemia in the very old (VO) subjects, as defined as people aged ≥75 years. Objective: The aim of this study was to assess risk factors for nosocomial candidemia in two groups of candidemia patients, consisting of VO patients (≥75 years) and adult and old (AO) patients (18–74 years). In addition, risk factors for death (30-day mortality) were analysed separately in the two groups. Methods: We included all consecutive candidemia episodes from January 2011 to December 2013 occurring in six referral hospitals in north-eastern Italy. Results: A total of 683 nosocomial candidemia episodes occurred. Of those, 293 (42.9%) episodes were in VO and 390 (57.1%) in AO patients. Hospitalization in medical wards, chronic renal failure, urinary catheter, and peripheral parenteral nutrition (PPN) were more common in VO than in AO patients. In the former patient group, adequate antifungal therapy (73.2%) and central venous catheter (CVC) removal (67.6%) occurred less frequently than in AO patients (82.5 and 80%, p < 0.002 and p < 0.004, respectively). Thirty-day mortality was higher in VO compared to AO patients (47.8 vs. 23.6%, p < 0.0001). In AO patients, independent risk factors for death were age (OR 1.04, 95% CI 1.00–1.09, p = 0.038), recent history of chemotherapy (OR 22.01, 95% CI 3.12–155.20, p = 0.002), and severity of sepsis (OR 40.68, 95% CI 7.42–223.10, p < 0.001); CVC removal was associated with higher probability of survival (OR 0.10, 95% CI 0.03–0.33, p < 0.001). In VO patients, independent risk factors for death were PPN (OR 3.5, 95% CI 1.17–10.47, p = 0.025) and hospitalization in medical wards (OR 2.58, 95% CI 1.02–6.53, p = 0.046), while CVC removal was associated with improved survival (OR 0.40, 95% CI 0.16–1.00, p = 0.050). Conclusion: Thirty-day mortality was high among VO patients and was associated with inadequate management of candidemia, especially in medical wards.
Clinical Features and Mortality of Nosocomial Candidemia in Very Old Patients: A Multicentre Italian Study | Gerontology | Karger Publishers
Table 2 - HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012–2017 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
Table 2 - HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012–2017 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
HIV-seropositive persons demonstrated increased adjusted risk for 30-day mortality and should be evaluated for intensive care.
Table 2 - HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012–2017 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document | Critical Care | Full Text
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document | Critical Care | Full Text
Rapid multiplex molecular syndromic panels (RMMSP) (3 or more pathogens and time-to-results < 6 h) allow simultaneous detection of multiple pathogens and genotypic resistance markers. Their implementation has revolutionized the clinical landscape by significantly enhancing diagnostic accuracy and reducing time-to-results in different critical conditions. The current revision is a comprehensive but not systematic review of the literature. We conducted electronic searches of the PubMed, Medline, Embase, and Google Scholar databases to identify studies assessing the clinical performance of RMMSP in critically ill patients until July 30, 2024. A multidisciplinary group of 11 Spanish specialists developed clinical questions pertaining to the indications and limitations of these diagnostic tools in daily practice in different clinical scenarios. The topics covered included pneumonia, sepsis/septic shock, candidemia, meningitis/encephalitis, and off-label uses of these RMMSP. These tools reduced the time-to-diagnosis (and therefore the time-to-appropriate treatment), reduced inappropriate empiric treatment and the length of antibiotic therapy (which has a positive impact on antimicrobial stewardship and might be associated with lower in-hospital mortality), may reduce the length of hospital stay, which could potentially lead to cost savings. Despite their advantages, these RMMSP have limitations that should be known, including limited availability, missed diagnoses if the causative agent or resistance determinants are not included in the panel, false positives, and codetections. Overall, the implementation of RMMSP represents a significant advancement in infectious disease diagnostics, enabling more precise and timely interventions. This document addresses relevant issues related to the use of RMMSP on different critically ill patient profiles, to standardize procedures, assist in making management decisions and help specialists to obtain optimal outcomes.
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document | Critical Care | Full Text
The risk and clinical outcome of candidemia depending on underlying malignancy | Intensive Care Medicine
The risk and clinical outcome of candidemia depending on underlying malignancy | Intensive Care Medicine
Purpose To assess the risk factors and outcomes associated with fungemia caused by the six most commonly occurring Candida species in patients with and without malignancies. Methods Analysis of the episodes of fungemia due to common Candida species in adults, based on an active hospital-based surveillance program (Paris area, France, 2002 to 2014). Results Of the 3417 patients (3666 isolates), 1164 (34.1%) had a solid tumor (45.7% digestive tract) and 586 (17.1%) a hematological malignancy (41.8% lymphoma, 33.5% acute leukemia). The hematology patients were significantly younger, more often pre-exposed to antifungals, more often infected by C. tropicalis, C. krusei, or C. kefyr, and more often treated in the first instance with an echinocandin. Compared with inpatients who were not in ICU at the time of fungemia, those in ICU were less frequently infected by C. parapsilosis (p < 0.02), had more recent surgery (p < 0.03), and died more frequently before day 8 and day 30 (p < 0.0001). An increase in crude mortality over time in ICU was observed only in oncology patients (p < 0.04). For all patients, lack of prescription of antifungals despite knowledge of positive blood culture increased the risk of death. The odds of being infected by a given Candida species compared with C. albicans were uneven regarding age, gender, type of malignancy, hospitalization in ICU, central venous catheter, HIV status, intravenous drug addiction, and previous exposure to antifungal drugs. Compared with C. albicans, C. glabrata (OR = 0.69 [0.54–0.89]) and C. parapsilosis (OR = 0.49 [0.35–0.67]) were associated with a decreased risk of death by day 8 and day 30. Conclusion The clinical context of underlying malignancy and hospitalization in ICU may be relevant to the initial management of candidemia.
The risk and clinical outcome of candidemia depending on underlying malignancy | Intensive Care Medicine
google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://air.uniud.it/retrieve/e7fa2de3-2407-4976-ab34-1bf4ebc487b9/Invasive%2520Candida%2520infection%2520epidemiology%2520clinical%2520and%2520therapeutic%2520aspects%2520of%2520an%2520evolving%2520disease%2520and%2520the%2520role%2520of%2520rezafungin.pdf&ved=2ahUKEwiylLSO-ZKOAxX1kokEHQSSM3I4MhAWegQIFhAB&usg=AOvVaw0wZ6WSu6mfi7aZTX8Cs2XD
google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://air.uniud.it/retrieve/e7fa2de3-2407-4976-ab34-1bf4ebc487b9/Invasive%2520Candida%2520infection%2520epidemiology%2520clinical%2520and%2520therapeutic%2520aspects%2520of%2520an%2520evolving%2520disease%2520and%2520the%2520role%2520of%2520rezafungin.pdf&ved=2ahUKEwiylLSO-ZKOAxX1kokEHQSSM3I4MhAWegQIFhAB&usg=AOvVaw0wZ6WSu6mfi7aZTX8Cs2XD
google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://air.uniud.it/retrieve/e7fa2de3-2407-4976-ab34-1bf4ebc487b9/Invasive%2520Candida%2520infection%2520epidemiology%2520clinical%2520and%2520therapeutic%2520aspects%2520of%2520an%2520evolving%2520disease%2520and%2520the%2520role%2520of%2520rezafungin.pdf&ved=2ahUKEwiylLSO-ZKOAxX1kokEHQSSM3I4MhAWegQIFhAB&usg=AOvVaw0wZ6WSu6mfi7aZTX8Cs2XD
Fullchan
Fullchan
Visit this link to see the note. Giving the URL to anyone allows them to access the note, too.
Fullchan
Fullchan
Fullchan
archived 13 Feb 2024 22:28:56 UTC
Fullchan
Fullchan
Fullchan
archived 4 Sep 2024 18:44:50 UTC
Fullchan
psyQop.gif - Animated GIF optimizer and compressor
psyQop.gif - Animated GIF optimizer and compressor
Free online tool for optimizing animated GIF images to reduce file size. Compress GIFs with LZW compression, reduce colors or frame rate, remove duplicate frames.
psyQop.gif - Animated GIF optimizer and compressor